Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
At present we cannot give a definitive answer because it has not been tried on all types, although a wide variety of cancers were used in the Michigan study. As a general rule, if the cancer depends on angiogenesis for growth, then TM should work. In addition to solid tumors, multiple myeloma, lymphoma, and leukemia are angiogenesis dependent.
